{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:07:32Z","timestamp":1767665252079},"reference-count":33,"publisher":"Wiley","issue":"1-2","license":[{"start":{"date-parts":[[2005,2,24]],"date-time":"2005-02-24T00:00:00Z","timestamp":1109203200000},"content-version":"vor","delay-in-days":54,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Pharma Physio"],"published-print":{"date-parts":[[2005,1]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>1.\u2002The aim of the present study was to investigate the potential energy preserving effect of permanent bilateral common carotid artery occlusion (BCCAO) towards additional systemic hypotension of severe duration (30\u00a0min). In addition, the role of adenosine A<jats:sub>1<\/jats:sub> receptors in cerebral ischaemic preconditioning was investigated in male Wistar rats. Thus, oligaemic rats were assigned randomly to continuous treatment with the adenosine A<jats:sub>1<\/jats:sub> receptor agonist 2\u2010chloro\u2010<jats:italic>N<\/jats:italic>6\u2010cyclopentyladenosine (CCPA) or the adenosine A<jats:sub>1<\/jats:sub> receptor antagonist 8\u2010cyclopentyl\u20101,3\u2010dimethylxanthine (CPT), receiving daily intraperitoneal infusions of 0.1\u00a0mg\/kg bodyweight CCPA or CPT or placebo (200\u00a0\u00b5L aqueous 2\u2010hydropropyl\u2010\u03b2\u2010cyclodextrin) at a delivery rate of 0.5\u00a0\u00b5L\/h over 14 days.<\/jats:p><jats:p>2.\u2002Haemodynamic parameters and arterial blood gases were monitored. Rat cortical energy metabolites ATP, ADP, AMP, phosphocreatine and adenosine were measured using HPLC techniques. Adenosine A<jats:sub>1<\/jats:sub> receptor expression was determined by immunhistochemistry and quantified by western blotting.<\/jats:p><jats:p>3.\u2002Two weeks of permanent BCCAO induced an \u2018energy saving\u2019 effect in rat cortical ATP concentrations. Under subchronic conditions, significant increases were detected in ADP and AMP concentrations after CCPA compared with placebo. Because similar changes were also seen after CPT, this adenosine A<jats:sub>1<\/jats:sub> receptor\u2010mediated effect does not seems to be specific. Furthermore, no differences in adenosine A<jats:sub>1<\/jats:sub> receptor expression could be detected.<\/jats:p><jats:p>4.\u2002Adenosine was not specifically involved in the \u2018preconditioning\u2010like\u2019 effect via the modulation of the adenosine A<jats:sub>1<\/jats:sub> receptor in the present oligaemia model. Obviously, adenosine A<jats:sub>1<\/jats:sub> receptor\u2010specific effects after delayed cerebral ischaemic preconditioning do not seem to play an essential role if BCCAO is followed by a prolonged additional severe ischaemic event.<\/jats:p>","DOI":"10.1111\/j.1440-1681.2005.04154.x","type":"journal-article","created":{"date-parts":[[2005,2,24]],"date-time":"2005-02-24T18:29:17Z","timestamp":1109269757000},"page":"54-59","source":"Crossref","is-referenced-by-count":4,"title":["Does permanent carotid artery occlusion produce a \u2018preconditioning\u2010like\u2019 effect towards more severe hypotension in energy metabolites? Role of cerebral adenosine"],"prefix":"10.1111","volume":"32","author":[{"given":"Konstanze","family":"Plaschke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Kreutzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eike","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert J","family":"Bardenheuer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,2,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(90)90189-I"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1993.28"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(93)90364-Q"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-200202000-00004"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00024382-199708000-00003"},{"key":"e_1_2_6_7_2","first-page":"H235","article-title":"Brain adenosine concentration during hypoxia in rats","volume":"241","author":"Winn HR","year":"1981","journal-title":"Am. J. Physiol."},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.35.2.262"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(02)00280-8"},{"key":"e_1_2_6_10_2","first-page":"L1036","article-title":"A1 adenosine receptor antagonists block ischemia\u2013reperfusion injury of the lung","volume":"268","author":"Neely CF","year":"1995","journal-title":"Am. J. Physiol."},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1006\/jsre.2000.5987"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.10.4666"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-7634(96)00011-5"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1999.tb07983.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0074-7742(08)60723-0"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(02)00495-0"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(01)02647-6"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(00)01950-8"},{"key":"e_1_2_6_19_2","first-page":"1023","article-title":"Pharmacological characterization of a simple behavioral response mediated selectively by central adenosine A1 receptors, using in vivo and in vitro techniques","volume":"285","author":"Marston HM","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00175797"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1462-5822.2007.00901.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(74)91049-X"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2828(91)90190-W"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.21.2.316"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1972.tb05322.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00702-003-0830-z","article-title":"Pronounced arterial collateralization was induced after permanent rat cerebral four\u2010vessel occlusion. Relation to neuropathology and capillary ultrastructure","volume":"110","author":"Plaschke K","year":"2003","journal-title":"J. Neural Transm."},{"key":"e_1_2_6_28_2","first-page":"H1327","article-title":"Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs","volume":"246","author":"Auchampach JA","year":"1993","journal-title":"Am. J. Physiol."},{"key":"e_1_2_6_29_2","first-page":"H829","article-title":"Cardioprotection provided by adenosine receptor activation is abolished by blockade of the KATP channel","volume":"266","author":"Van Winkle DM","year":"1994","journal-title":"Am. J. Physiol."},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/27.4.669"},{"key":"e_1_2_6_31_2","first-page":"616","article-title":"Pharmacokinetic\u2013pharmacodynamic relationship of the cardiovascular effects of adenosine A1 receptor agonist N6\u2010cyclopentyladenosine in the rat","volume":"268","author":"Mathot RA","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1995.tb15033.x"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(89)90208-7"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2000.0740327.x"}],"container-title":["Clinical and Experimental Pharmacology and Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1681.2005.04154.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1681.2005.04154.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T10:27:24Z","timestamp":1693477644000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1681.2005.04154.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":33,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["10.1111\/j.1440-1681.2005.04154.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1681.2005.04154.x","archive":["Portico"],"relation":{},"ISSN":["0305-1870","1440-1681"],"issn-type":[{"value":"0305-1870","type":"print"},{"value":"1440-1681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}